rs4646421

Variant summary

Our verdict is Benign.
<-10 Benign
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received -12 classification points (ACMG Germline Pathogenicity v2019). BA1BP4_Strong

The NM_001319217.2(CYP1A1):c.-29-725C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a cumulative frequency of 0.215 (AC=32,708) in the gnomAD database across 152,078 control chromosomes, including 4,844 homozygotes. The grpmax filtering allele frequency (95% CI) is 0.395. In-silico predictor (BayesDel (noAF)) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.22 ( 4844 hom., cov: 31)

Consequence

CYP1A1
NM_001319217.2 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.265

Publications

69 publications found
Variant links:
Genes affected
CYP1A1 (HGNC:2595): (cytochrome P450 family 1 subfamily A member 1) This gene, CYP1A1, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by some polycyclic aromatic hydrocarbons (PAHs), some of which are found in cigarette smoke. The enzyme's endogenous substrate is unknown; however, it is able to metabolize some PAHs to carcinogenic intermediates. The gene has been associated with lung cancer risk. A related family member, CYP1A2, is located approximately 25 kb away from CYP1A1 on chromosome 15. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Jan 2016]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_001319217.2, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACMG Germline Pathogenicity v2019

Classification was made for transcript:

Our verdict: Benign. The variant received -12 points.

BP4Computational evidence suggests no impact
Computational evidence supports benign — no pathogenic computational or splicing signal (BP4); Splicing verdict: benign (Strong).; Germline computational verdict: benign (Strong).
BA1Stand-alone benign allele frequency (>5%)
GnomAD effective popmax AF >5% — BA1 stand-alone benign; GnomAD reliable popmax AF = 0.3954 — exceeds 5%% threshold (BA1 applied)

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_001319217.2. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CYP1A1
NM_001319217.2
MANE Select
c.-29-725C>T
intron
N/ANP_001306146.1A0N0X8
CYP1A1
NM_000499.5
c.-26-728C>T
intron
N/ANP_000490.1A0N0X8
CYP1A1
NM_001319216.2
c.-29-725C>T
intron
N/ANP_001306145.1E7EMT5

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CYP1A1
ENST00000379727.8
TSL:1 MANE Select
c.-29-725C>T
intron
N/AENSP00000369050.3P04798-1
CYP1A1
ENST00000395048.6
TSL:1
c.-26-728C>T
intron
N/AENSP00000378488.2P04798-1
CYP1A1
ENST00000567032.5
TSL:1
c.-29-725C>T
intron
N/AENSP00000456585.1P04798-1

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 4 sources
GnomAD3 genomes
AF: 0.215
AC:32628
Hom:4823
AN:151960
Cov:31
GnomAD4 genome
AF: 0.215
AC:32708
Hom:4844
AN:152078
Cov:31
TOPMed (Bravo)
AF: 0.236
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.145
AC:45174
Hom:4868
AN:310600
Local & regional cohorts 10 sources
ABraOM SABE-WGS-1171
AF: 0.226
AC:530
Hom:74
AN:2342
ChinaMAP Phase 1
AF: 0.409
Denmark Genome
AF: 0.110
AC:33
AN:300
GenomeAsia100K
AF: 0.419
AC:1452
AN:3478
Korea4K (4,157 Koreans)
AF: 0.384
AC:2775
AN:7232
Qatari Genome
AF: 0.142
AC:25
AN:176
ToMMo 61KJPN (+60KJPN MNV)
AF: 0.366
AC:44822
Hom:8280
AN:122618
Turkish Variome
AF: 0.155
AC:239
Hom:23
AN:1546
UK10K
AF: 0.106
AC:805
AN:7562
WBBC (Westlake BioBank for Chinese) pilot
AF: 0.416
AC:3729
Hom:755
AN:8960
Showing 14 sources
Tested, but no data found:GnomAD4 exomeIf GnomAD4 is missing, the position is probably not covered by the project.

ClinVar

Not reported in ClinVar

Computational Scores

AlphaGenome AVI
Uncertain11
BayesDel_noAF
Benign-0.78
CADD
Benign4.9
DANN
Benign0.68
GPN-Star LLR
N/A-0.36
GPN-Star score
N/A0.36
Mutation Taster
N/A100/0polymorphism (auto)
PhyloP100
Benign-0.27
Showing 8 of 8 scores

Splicing Scores

Pangolin (max)
Benign0.0
SpliceAI score (max)
Benign0.0
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.